Two new chiefs join Pronota
This article was originally published in Scrip
Pronota, a developer of first-in-class diagnostics for early detection of life-threatening conditions, has appointed Carol Greeve-Philips chief business officer and Els Hubloux chief financial officer. Ms Greeve-Philips joins Pronota from Genzyme, where she most recently served as vice-president of corporate development. Ms Hubloux has a background in clinical research and development, equity research and venture capital investments and joins Pronota from Capricorn Venture Partners.